[go: up one dir, main page]

BR0311511A - Preparações farmacêuticas para a aplicação oral contendo resinas trocadoras de ìons carregadas com substância ativa bem como formadores de gel de estrutura viscosa como espessante - Google Patents

Preparações farmacêuticas para a aplicação oral contendo resinas trocadoras de ìons carregadas com substância ativa bem como formadores de gel de estrutura viscosa como espessante

Info

Publication number
BR0311511A
BR0311511A BR0311511-9A BR0311511A BR0311511A BR 0311511 A BR0311511 A BR 0311511A BR 0311511 A BR0311511 A BR 0311511A BR 0311511 A BR0311511 A BR 0311511A
Authority
BR
Brazil
Prior art keywords
pharmaceutical preparations
oral application
well
active substance
ion exchange
Prior art date
Application number
BR0311511-9A
Other languages
English (en)
Inventor
Dirk Mertin
Markus Edingloh
Gert Daube
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of BR0311511A publication Critical patent/BR0311511A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"PREPARAçõES FARMACêUTICAS PARA A APLICAçãO ORAL CONTENDO RESINAS TROCADORAS DE ìONS CARREGADAS COM SUBSTâNCIA ATIVA BEM COMO FORMADORES DE GEL DE ESTRUTURA VISCOSA COMO ESPESSANTE". A presente invenção refere-se a preparações farmacêuticas para a aplicação oral, as quais contêm uma ou mais substâncias ativas, que são ligadas a um trocador de íons. Para o aperfeiçoamento da estabilidade física e da aceitância, especialmente nos animais, um formador de gel de estrutura viscosa está contido como espessante.
BR0311511-9A 2002-05-31 2003-05-19 Preparações farmacêuticas para a aplicação oral contendo resinas trocadoras de ìons carregadas com substância ativa bem como formadores de gel de estrutura viscosa como espessante BR0311511A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10224086A DE10224086A1 (de) 2002-05-31 2002-05-31 Pharmazeutische Zubereitungen zur oralen Anwendung enthaltend wirkstoffbeladene Ionentauscherharze sowie strukturviskose Gelbildner als Verdicker
PCT/EP2003/005228 WO2003101422A2 (de) 2002-05-31 2003-05-19 Pharmazeutiche zubereitungen zur oralen anwendung enthaltend wirkstoffbeladene ionentauscherharze sowie strukturviskose gelbildner als verdicker

Publications (1)

Publication Number Publication Date
BR0311511A true BR0311511A (pt) 2005-02-22

Family

ID=29432468

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0311511-9A BRPI0311511B1 (pt) 2002-05-31 2003-05-19 "preparações farmacêuticas líquidas, e sua aplicação".
BR0311511-9A BR0311511A (pt) 2002-05-31 2003-05-19 Preparações farmacêuticas para a aplicação oral contendo resinas trocadoras de ìons carregadas com substância ativa bem como formadores de gel de estrutura viscosa como espessante

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BRPI0311511-9A BRPI0311511B1 (pt) 2002-05-31 2003-05-19 "preparações farmacêuticas líquidas, e sua aplicação".

Country Status (28)

Country Link
US (1) US8545829B2 (pt)
EP (1) EP1513500B1 (pt)
JP (2) JP5350574B2 (pt)
KR (3) KR101258373B1 (pt)
CN (1) CN1671361B (pt)
AR (2) AR039861A1 (pt)
AT (1) ATE421317T1 (pt)
AU (1) AU2003242545B2 (pt)
BR (2) BRPI0311511B1 (pt)
CA (1) CA2487648C (pt)
CR (1) CR7598A (pt)
DE (2) DE10224086A1 (pt)
DK (1) DK1513500T3 (pt)
ES (1) ES2319115T3 (pt)
HK (1) HK1083200A1 (pt)
HR (1) HRP20041219B1 (pt)
IL (2) IL165322A0 (pt)
MX (1) MXPA04011820A (pt)
MY (1) MY140953A (pt)
NO (1) NO333939B1 (pt)
PL (1) PL207269B1 (pt)
PT (1) PT1513500E (pt)
RU (1) RU2380091C2 (pt)
SI (1) SI1513500T1 (pt)
TW (1) TWI333422B (pt)
UA (1) UA84270C2 (pt)
WO (1) WO2003101422A2 (pt)
ZA (1) ZA200409616B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004001558A1 (de) * 2004-01-10 2005-08-18 Bayer Healthcare Ag Arzneimittel zur topischen Applikation bei Tieren
US20080095842A1 (en) * 2004-12-06 2008-04-24 Antarkar Amit K Rapidly Disintegrating Taste Masked Compositions and a Process for Its Preparations
DE102005025900A1 (de) * 2005-06-06 2006-12-07 Basf Ag Verfahren zur Entfernung von Salzen aus einem Alkoxycarbonylaminotriazin enthaltenden Reaktionsgemisch
US20080051332A1 (en) * 2005-11-18 2008-02-28 Nastech Pharmaceutical Company Inc. Method of modulating hematopoietic stem cells and treating hematologic diseases using intranasal parathyroid hormone
CN100360131C (zh) * 2006-01-24 2008-01-09 新昌国邦化学工业有限公司 一种掩味恩诺沙星的生产方法
US20070248564A1 (en) * 2006-04-25 2007-10-25 Roxane Laboratories, Inc. Formulation of sodium polystyrene sulfonate suspension for the treatment of hyperkalemia
EP2066302A2 (en) 2006-09-26 2009-06-10 Taro Pharmaceuticals North America, Inc. Stabilizing compositions for antibiotics and methods of use
DE102006049520A1 (de) 2006-10-20 2008-04-24 Bayer Healthcare Ag Verfahren zur Herstellung von Pradofloxacin
US20080118570A1 (en) * 2006-11-20 2008-05-22 Zhi Liu Polymer coated drug-ion exchange resins and methods
EP2262536A4 (en) * 2008-03-26 2013-07-03 Taro Pharmaceuticals North America Inc STABILIZING LIPID COMPOSITIONS FOR ORAL PHARMACEUTICAL AGENTS
NZ602120A (en) 2010-03-12 2015-02-27 Monsanto Technology Llc Agrochemical gel compositions
BR112012029461A2 (pt) * 2010-05-19 2017-03-01 Astellas Pharma Inc composição farmacêutica contendo solifenacina
JP2014530855A (ja) 2011-10-19 2014-11-20 アール．ピー． シェーラーテクノロジーズ エルエルシー 二相式薬剤送達システム
FR2998305B1 (fr) * 2012-11-22 2015-02-20 Henkel Ag & Co Kgaa Substances actives contenant des groupes sulfonates ameliorant la puissance de lavage primaire
KR101697095B1 (ko) * 2015-09-30 2017-01-18 주식회사 포스코 더스트 막힘을 방지할 수 있는 배가스 청정 라인의 실탱크
CR20200502A (es) 2018-04-25 2020-12-22 Bayer Animal Health Gmbh Proceso para la hidrólisis de ésteres carboxílicos de quinolona
CN114249749B (zh) * 2022-01-08 2024-03-22 天象生物药业邢台有限责任公司 一种马波沙星甲酸盐的转化方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60204713A (ja) * 1984-03-30 1985-10-16 Zenyaku Kogyo Kk 水性懸濁組成物
GB8618847D0 (en) * 1986-08-01 1986-09-10 Smith Kline French Lab Pharmaceutical formulations
DE3719764A1 (de) * 1987-06-13 1988-12-22 Bayer Ag Ionenaustauscherharze beladen mit chinoloncarbonsaeurederivaten, ihre herstellung und verwendung
US5338732A (en) * 1991-06-18 1994-08-16 Bristol-Myers Squibb Company Megestrol acetate formulation
CZ94394A3 (en) * 1991-10-28 1994-12-15 Procter & Gamble Beverage system thickener/emulsifying agent and process for preparing a beverage with such system
JP3207494B2 (ja) * 1992-04-02 2001-09-10 ロート製薬株式会社 水性懸濁製剤
DE4319649A1 (de) * 1993-03-18 1994-09-22 Asta Medica Ag Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
EP0882049B1 (de) * 1996-02-23 2002-11-20 Bayer Ag Gegebenenfalls substituierte 8-cyan-1-cyclopropyl-7-(2,8-diazabicyclo- 4.3.0]-nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäuren und ihre derivate
US5980882A (en) * 1997-04-16 1999-11-09 Medeva Pharmaceuticals Manufacturing Drug-resin complexes stabilized by chelating agents
DE19854357A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
PL202027B1 (pl) * 1999-07-14 2009-05-29 Schering Plough Ltd Wodna farmaceutyczna kompozycja zawierająca związek chinolonowy
GB9930058D0 (en) * 1999-12-20 2000-02-09 Novartis Ag Organic compounds
GB0020089D0 (en) 2000-08-15 2000-10-04 Smithkline Beecham Biolog Vaccine Composition
DE10134719A1 (de) * 2001-07-17 2003-02-06 Bayer Ag Pharmazeutische Zubereitungen enthaltend wirkstoffbeladene Ionentauscherharze
US7001667B2 (en) * 2002-07-17 2006-02-21 Ppg Industries Ohio, Inc. Alkyd-based free radical wood coating compositions

Also Published As

Publication number Publication date
IL165322A0 (en) 2006-01-15
CA2487648A1 (en) 2003-12-11
TW200406230A (en) 2004-05-01
HRP20041219B1 (hr) 2013-05-31
EP1513500B1 (de) 2009-01-21
JP2006503806A (ja) 2006-02-02
JP2011012087A (ja) 2011-01-20
EP1513500A2 (de) 2005-03-16
BRPI0311511B1 (pt) 2018-07-10
WO2003101422A2 (de) 2003-12-11
RU2380091C2 (ru) 2010-01-27
DE10224086A1 (de) 2003-12-11
UA84270C2 (ru) 2008-10-10
PL373456A1 (en) 2005-08-22
PT1513500E (pt) 2009-04-02
MY140953A (en) 2010-02-12
AU2003242545A1 (en) 2003-12-19
DK1513500T3 (da) 2009-05-11
CA2487648C (en) 2012-03-13
ES2319115T3 (es) 2009-05-04
ATE421317T1 (de) 2009-02-15
DE50311123D1 (de) 2009-03-12
JP5350574B2 (ja) 2013-11-27
CR7598A (es) 2008-07-31
WO2003101422A3 (de) 2004-12-09
NO20045700L (no) 2004-12-29
US8545829B2 (en) 2013-10-01
HRP20041219A2 (en) 2006-02-28
NO333939B1 (no) 2013-10-28
PL207269B1 (pl) 2010-11-30
KR20120123607A (ko) 2012-11-08
MXPA04011820A (es) 2005-03-31
AR039861A1 (es) 2005-03-02
SI1513500T1 (sl) 2009-06-30
KR20050010015A (ko) 2005-01-26
BRPI0311511A (pt) 2005-02-22
ZA200409616B (en) 2006-05-31
HK1083200A1 (en) 2006-06-30
BRPI0311511A8 (pt) 2017-07-11
RU2004139022A (ru) 2005-07-10
IL165322A (en) 2015-11-30
CN1671361A (zh) 2005-09-21
US20060177414A1 (en) 2006-08-10
TWI333422B (en) 2010-11-21
CN1671361B (zh) 2010-05-12
KR20120006092A (ko) 2012-01-17
AR105798A2 (es) 2017-11-08
AU2003242545B2 (en) 2010-02-18
KR101258373B1 (ko) 2013-04-30

Similar Documents

Publication Publication Date Title
BR0311511A (pt) Preparações farmacêuticas para a aplicação oral contendo resinas trocadoras de ìons carregadas com substância ativa bem como formadores de gel de estrutura viscosa como espessante
PT723437E (pt) Preparacao farmaceutica por unidades multiplas contendo um inibidor da bomba de protoes
BR0114927A (pt) Composição de gel farmacêutica substancialmente não aquosa para aplicação na pele, e, uso da composição
BR0207726A (pt) Sais farmacêuticos
ATE361084T1 (de) Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
BR0100046A (pt) Copolìmeros reticulados solúveis em água ou intumescìveis em água
BRPI0411982A (pt) glicano de aperfeiçoamento de terapia
BR9815570A (pt) Composto, processo de preparação dos compostos, utilização de pelo menos um composto, composição cosmética ou farmacêutica e utilização de pelos menos um polìmero
BRPI0013010B8 (pt) formulação aquosa de cloreto de sódio de moxifloxacina, processo para sua preparação e aplicação da referida formulação, bem como preparado de combinação e aplicação de uma solução aquosa de cloridrato de moxifloxacina
BR9801652A (pt) Resorcinil-triazinas
BR0014946A (pt) Uso de dipiridamol ou mopidamol na fabricação de um medicamento para o tratamento e prevenção de distúrbios da microcirculação dependentes da fibrina
DE69718734D1 (de) Bicyclische aromatische verbindungen
ES2168457T3 (es) Composiciones farmaceuticas que comprenden una superoxido dismutasa.
BR9702074A (pt) Compostos biaril heterocíclicos composições farmacêuticas e cosméticas que os contêm e suas utilizações
EA199700381A1 (ru) Диароматические соединения пропинила или диенила, промежуточные соединения, фармацевтические и косметические композиции на основе указанных соединений и применение косметических композиций
BRPI0611526A2 (pt) composição tópica contendo gelatina
ATE407658T1 (de) Lipid-transferprotein - systeme und deren kosmetische dermatologische anwendung
ES2124861T3 (es) Derivados de aminoacidos y su utilizacion como inhibidores de la encefalinasa.
BR9911833A (pt) Compostos diaril selenetos, composição farmacêutica, cosmética e sua utilização em medicina humana e veterinária, bem como em cosmetologia
BR9904890A (pt) "compostos de heteroetinileno, composição farmacêutica, composição cosmética e utilização de uma composição cosmética"
BR0211149A (pt) Preparados farmacêuticos contendo resinas trocadoras de ìons carregadas com substância ativa
DE69403110D1 (de) Zyklische Angiopeptin Derivate, deren Herstellung und pharmazeutische Zusammensetzungen
BR0210063A (pt) Composição estável e uso da mesma
BR0309786A (pt) Compostos, seu uso, composição farmacêutica, composição cosmética e uso cosmético de uma composição
BR0002381A (pt) Agente para aumentar a liberação de acetilcolina no cérebro

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: BAYER ANIMAL HEALTH GMBH (DE)

Free format text: TRANSFERIDO DE: BAYER HEALTHCARE AG

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA: INT. CL. A61K 9/10, 47/48, 31/44, 31/4709; A61P 31/00

Ipc: A61K 9/10 (2011.01), A61K 47/48 (2011.01), A61K 31

B25A Requested transfer of rights approved

Owner name: BAYER INTELLECTUAL PROPERTY GMBH (DE)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A61K 9/10 , A61K 47/48 , A61K 31/44 , A61K 31/4709 , A61P 31/00

Ipc: A61K 9/10 (2006.01), A61K 31/44 (2006.01), A61K 31

Ipc: A61K 9/10 (2006.01), A61K 31/44 (2006.01), A61K 31

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]